Prenatal Genetic Testing
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
70
NCT05733689
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
Phase: Phase 1
Role: Collaborator
Start: Jun 27, 2025
Completion: Feb 28, 2026
NCT07096362
Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
Phase: Phase 2
Start: Sep 9, 2025
Completion: Sep 30, 2030
Loading map...